efgartigimod

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of remote gas drilling infrastructure in Australia, illustrating how Tamboran Resources Corporation’s Falcon Oil & Gas acquisition could reshape the Beetaloo Basin energy story.

Tamboran (TBN) closes Falcon Oil & Gas deal, but the real test now moves to Beetaloo gas delivery

Eli Lilly (LLY) reclaims a $1tn valuation as Wall Street bets on its next weight-loss drug

Florida sues OpenAI and Sam Altman as child-safety fight hits generative AI

Representative image of a rail manufacturing yard with modern passenger coaches and freight wagons, illustrating Titagarh Rail Systems’ Q4 FY26 execution challenge as investors track its order book, Vande Bharat pipeline and railway manufacturing growth outlook.

Titagarh Rail Systems (NSE: TITAGARH) Q4 FY26 results: Why the order book looks strong but the FY27 execution test now matters more

Representative image of FcRn-targeted biologics including nipocalimab and efgartigimod used in generalized myasthenia gravis treatment

How does nipocalimab compare to efgartigimod and rozanolixizumab? FcRn class battlelines in gMG and beyond

Compare nipocalimab, efgartigimod, and rozanolixizumab on efficacy, safety, dosing, pricing, and market strategy in generalized myasthenia gravis treatment.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

June 26, 2025